Primary prevention statin trials
WebApr 11, 2024 · A planned interim analysis of data from the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) study found that participants who took pitavastatin calcium, a daily statin, lowered their ... WebJul 9, 2024 · In addition in Malaysia, 65% had a statin therapy prescription for primary prevention in T2D . Although utmost contemporary clinical practice guidelines endorsed that statin use in those T2D patients with the age group between 40 and 75 years for reducing cardiovascular risks and all-cause mortality are proven significantly, underutilization of …
Primary prevention statin trials
Did you know?
WebJul 1, 2024 · Benefits from statin therapy for the primary prevention of atherosclerotic cardiovascular disease (ASCVD) are supported by high-quality evidence from randomised … WebAtorvastatin has been extensively studied in the primary and secondary prevention of cardiovascular events, and may have some clinical advantages over various other statins …
WebRecommendation The USPSTF recommends that clinicians prescribe a statin for the primary prevention of CVD for adults aged 40 to 75 years who have 1 or more CVD risk factors (ie … WebThis Review is intended to help clinicians, patients, and the public make informed decisions about statin therapy for the prevention of heart attacks and strokes. It explains how the …
WebIn the recently published Justification for the Use of Statins in Primary An Intervention Tri ... The Gravity of JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) James H. O'Keefe, Maia D. Carter, Carl J. Lavie WebMar 30, 2024 · Sasso FC, Lascar N, Ascione A, Carbonara O, De Nicola L, Minutolo R, Salvatore T, Rizzo MR, Cirillo P, Paolisso G, Marfella R; NID-2 study group. Moderate …
WebThe fraction of statin dispensing for primary prevention decreased with age: higher for incident than prevalent prescribing. Independent of age, this fraction was highest among …
Web2 days ago · Large trial finds that pitavastatin lowered the risk for major cardiovascular events by 35%. The REPRIEVE study, a large global trial testing a statin for HIV-positive people at low to moderate risk for cardiovascular disease, was halted ahead of schedule after interim results showed that the medication significantly reduced the risk for heart ... intact soilWebMar 30, 2024 · Sasso FC, Lascar N, Ascione A, Carbonara O, De Nicola L, Minutolo R, Salvatore T, Rizzo MR, Cirillo P, Paolisso G, Marfella R; NID-2 study group. Moderate-intensity statin therapy seems ineffective in primary cardiovascular prevention in patients with type 2 diabetes complicated by nephropathy. A multicenter prospective 8 years follow up study. … intact sketchpadWebor based upon the indication for the prescribed statin (eg, primary vs secondary prevention). Studies that measured adherence by self-report had less heterogeneity (I2 0.45, P value for heterogeneity 0.12) and demonstrated higher odds of nonadherence for women (OR 1.20, 95% CI 1.0-1.44) compared with studies that used pharmacy claims intact souscriptionWebApr 13, 2024 · 13 April 2024. A National Institutes of Health (NIH) clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV. This was the first large-scale clinical study to test a primary cardiovascular prevention strategy in this population. jobs new brightonWebOct 1, 2024 · Current Literature. In patients age 75 and younger, the efficacy of statins for primary prevention is well-established on the basis of multiple randomized trials, which have found that they reduce the relative risk of major vascular events by 20-30%. 2,3 Given the … intact special riskWebApr 12, 2024 · Statin Primary Prevention Trial in HIV Halted for Efficacy. April 12, 2024 Frank Herd Leave a comment. Interim data from the REPRIEVE study showed that a daily statin cut the risk for cardiovascular events by 35% in … jobs net worth 2021WebIn a diverse sample of LMICs, statins are used by about one in ten eligible people for the primary prevention of cardiovascular diseases and one in five eligible people for … jobs neurosurgery research